Two recently approved agents offer significant activity against these hard-to-treat conditions.
New agents are in development, but none represent a magic bullet for the problems that CRE infections present.
The phase 3 study met its primary and secondary end points of all-cause mortality, microbiological eradication rates, and new Staphylococcus aureus bacteremia complications.
Two recently approved agents offer significant activity against these hard-to-treat conditions.
Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.
Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects
A novel study from Seddon and colleagues adds to the body of evidence that supports what antimicrobial stewardship programs are so often challenged to do, early de-escalation.
Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.
Studies have shown high rates of inappropriate antibiotic prescribing and opportunity for improvement when it comes to ABSSSIs.
Differences in the clinical presentations of ZIKV infection which are occurring in different parts of the world might be an obstacle to setting a case definition that is good for use in all areas.
Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
The clinical characteristics and outcomes of Pneumocystis jirovecii pneumonia differ in immunocompromised patients with and without HIV.
The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.
Lyme Disease Association President, Pat Smith, takes on the major problems surrounding Lyme disease today.
“A bite bug in the belly.”
In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.
Cross-contamination of eggs is believed to have been the cause of a Salmonella outbreak from an Australian hotel.
Additionally, its use is associated with colonization of the gastrointestinal tract by lower relative quantities of some potentially protective bacterial organisms.
The study was designed to help scientists better understand how to prevent in-hospital transmission of C difficile.
This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.
Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.
The vaccine is based on an attenuated rabies vaccine that was subsequently inactivated to make the vaccine candidate. The National Institutes of Health (NIH) is sponsoring the trial.
Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.
The NFID released data revealing that only 52% of adults in the United States plan to get vaccinated against the flu this season.
Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects
Candida auris is an emerging health care–associated multidrug-resistant fungal pathogen with public health concerns more similar to those of extensively drug-resistant bacterial pathogens than other species of Candida.